Lux Health Tech Acquisition Corp.
LUXAW
NASDAQ Capital Market0.00
USD
- -
- -
CIK
0001823767
Return %
Stock
S&P500
1Y
- -
18.02
3Y
-97.75
64.11
5Y
-99.82
72.15
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- IPO Date
- Dec 22, 2020
- CIK
- 0001823767
- Similar Companies
- Business
- Lux Health Tech Acquisition Corp. operates as a blank check company whose purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company targets businesses at the intersection of the healthcare and technology industries; it has not commenced substantive operations or generated revenue. Incorporated in 2020 and headquartered at 920 Broadway, 11th Floor, New York, New York, the company went public in October 2020 raising $300 million through 30 million units comprising one share of Class A common stock and one-third of a warrant (ticker: LUXAW) exercisable at $11.50 per share. In September 2022, Lux Health Tech Acquisition entered a non-binding letter of intent for a business combination with an unnamed life sciences company featuring an experienced leadership team and multiple development programs, backed by prominent investors, under which the target's equityholders would roll 100% into the combined public entity. However, the company cancelled its special stockholder meeting in October 2022, failed to complete an initial business combination by the required deadline under its charter, and liquidated on October 29, 2022, redeeming public shares at approximately $10.04 per share while its warrants expired worthless; Nasdaq subsequently delisted its securities, and the company terminated its SEC reporting registration.